http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3055331-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81fb736bb33a8f5086e3d7a3c6dc65be |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-02 |
| filingDate | 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9bacf6f4bafc9dc8f09e402c58158fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce695bf167f322a0d7d8ef35c1cf0a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_518dd0455def57a4e4b8f795e13768fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1291769b931380b0359f6ac12488b4f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3e68f4eacfce57ebab293e0f792d16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2933b93d0974f5e36e392e6b2246faad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8704bdf1771316a49b52490136537c75 |
| publicationDate | 2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-3055331-A1 |
| titleOfInvention | NMDA RECEPTOR MODULATORS, COMPOSITIONS COMPRISING THEM AND THE USE THEREOF IN THE TREATMENT OF DISEASES INVOLVING THE CENTRAL NERVOUS SYSTEM |
| abstract | The present invention relates to the field of prevention and treatment of diseases involving NMDA receptors of the central nervous system. More specifically, it relates to indol-1-yl- (1-H) -quinolin-2-one and indol-3-yl- (1-H) -quinolin-2-one compounds, especially as medicaments, and the use of such compounds in the preparation of pharmaceutical compositions. These pharmaceutical compositions may especially be intended to prevent or treat diseases involving NMDA receptors of the central nervous system, in particular severe / resistant epilepsy and the resulting cognitive disorders, in particular autism, but also cerebrovascular accidents. , schizophrenia, degenerative diseases involving the activation of NMDA receptors such as Parkinson's and Alzheimer's disease, Rett syndrome or amyotrophic lateral sclerosis, migraine, dementia and major depression. |
| priorityDate | 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.